BCV Asset Management Inc.

Position in CING — Cingulate Inc.

CIK 2110721 WINNIPEG, A2

Position in CING

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$317,952

New position

Shares Held

51,200

first reported quarter

Ownership

0.386%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BCV Asset Management Inc. holds $438,303 across 4 Biotechnology names. CING ranks #1 (72.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CING	Cingulate Inc. This page	51,200	$317,952
2	ACHV	Achieve Life Sciences, Inc.	26,365	$77,513
3	GOSS	Gossamer Bio, Inc.	106,500	$35,038
4	LEXX	Lexaria Bioscience Corp.	10,000	$7,800

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$317,952	51,200	—	Shares	Sole	2026-05-08
No filing history on record for this holder in this stock.